Please enable JavaScript to continue using this application.

Compare $KRRO vs $NKTX | Chartloom

Compare

$KRRO vs $NKTX

Korro Bio Inc · Nkarta Inc

KRRO

Korro Bio Inc

NKTX

Nkarta Inc

Compare $KRRO vs $NKTX

Comparing Korro Bio Inc and Nkarta Inc

KRROKorro Bio Inc

NKTXNkarta Inc

KRROKorro Bio Inc

Market cap

$147M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

143.63x

Rev growth (TTM)

-62.1%

YTD performance

26.2%

52W performance

-77.8%

FCF yield

-46.6%

NKTXNkarta Inc

Market cap

$161M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

20.3%

52W performance

7.7%

FCF yield

-58.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KRRO

NKTX

Detailed metrics comparison

KRRO

Korro Bio Inc

NKTX

Nkarta Inc

Market Cap

KRRO$147M

NKTX$161M

Enterprise Value

KRRO$122M

NKTX$136M

Price

KRRO$10.16

NKTX$2.25

P/E Ratio

KRRON/A

NKTXN/A

P/S Ratio

KRRO61.51x

NKTX0.00x

EV/Sales

KRRO51.05x

NKTX0.00x

EV/EBITDA

KRRO0.00x

NKTX0.00x

P/B Ratio

KRRO1.38x

NKTX0.74x

P/FCF Ratio

KRRON/A

NKTXN/A

EV/FCF

KRRO-1.78x

NKTX-1.45x

PEG Ratio

KRRON/A

NKTXN/A

Forward P/E (NTM)

KRRON/A

NKTXN/A

Forward P/S (NTM)

KRRO143.63x

NKTXN/A

Revenue (TTM)

KRRO$2M

NKTX$0

Revenue Growth (YoY)

KRRO-62.1%

NKTXN/A

Forward Rev Growth

KRRO240.0%

NKTX2561.2%

Gross Margin (TTM)

KRRO0.0%

NKTX0.0%

Operating Margin (TTM)

KRRO0.0%

NKTX0.0%

EBITDA Margin (TTM)

KRRO-3068.6%

NKTX0.0%

Net Margin (TTM)

KRRO-4477.1%

NKTX0.0%

FCF Margin (TTM)

KRRO-2865.9%

NKTXN/A

Net Income (TTM)

KRRO$-107M

NKTX$-117M

FCF (TTM)

KRRO$-68M

NKTX$-94M

EPS (TTM)

KRRO-$6.05

NKTX-$1.57

ROE (TTM)

KRRO-11426.0%

NKTX-3964.0%

ROA (TTM)

KRRO-6857.0%

NKTX-3045.0%

ROIC (TTM)

KRRO-11426.0%

NKTX-3964.0%

Cash

KRRO$25M

NKTX$25M

Debt

KRRO$0

NKTX$0

Net Cash/Debt

KRRO$25M

NKTX$25M

Current Ratio (TTM)

KRRO9.55x

NKTX7.98x

Quick Ratio (TTM)

KRRO9.11x

NKTX7.76x

Debt/Equity (TTM)

KRRO0.00x

NKTX0.00x

Debt/Assets (TTM)

KRRO0.0%

NKTX0.0%

Interest Coverage (TTM)

KRRON/A

NKTXN/A

Net Debt/EBITDA (TTM)

KRRO0.00x

NKTX0.00x

Beta

KRRO3.27

NKTX1.19

52W Performance

KRRO-77.8%

NKTX7.7%

YTD Performance

KRRO26.2%

NKTX20.3%

% from 52W High

KRRO-81.8%

NKTX-39.5%

% from 52W Low

KRRO95.2%

NKTX32.4%

Asset Turnover (TTM)

KRRO0.04x

NKTX0.00x

FCF Yield (TTM)

KRRO-46.6%

NKTX-58.3%

Earnings Yield (TTM)

KRRO-72.8%

NKTX-72.9%

Dividend Yield (TTM)

KRRON/A

NKTXN/A

Rule of 40

KRRO-2,927.9

NKTX0.0

EV/GP/RG

KRRON/A

NKTXN/A

Ticker research

View KRRO research View NKTX research

Metric	KRRO Korro Bio Inc	NKTX Nkarta Inc
Market & Valuation
Market Cap	$147M	$161M
Enterprise Value	$122M	$136M
Price	$10.16	$2.25
P/E Ratio	N/A	N/A
P/S Ratio	61.51x	0.00x
EV/Sales	51.05x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.38x	0.74x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.78x	-1.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	143.63x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-62.1%	N/A
Forward Rev Growth	240.0%	2561.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3068.6%	0.0%
Net Margin (TTM)	-4477.1%	0.0%
FCF Margin (TTM)	-2865.9%	N/A
Net Income (TTM)	$-107M	$-117M
FCF (TTM)	$-68M	$-94M
EPS (TTM)	-$6.05	-$1.57
ROE (TTM)	-11426.0%	-3964.0%
ROA (TTM)	-6857.0%	-3045.0%
ROIC (TTM)	-11426.0%	-3964.0%
Financial Health
Cash	$25M	$25M
Debt	$0	$0
Net Cash/Debt	$25M	$25M
Current Ratio (TTM)	9.55x	7.98x
Quick Ratio (TTM)	9.11x	7.76x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.27	1.19
52W Performance	-77.8%	7.7%
YTD Performance	26.2%	20.3%
% from 52W High	-81.8%	-39.5%
% from 52W Low	95.2%	32.4%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.00x
FCF Yield (TTM)	-46.6%	-58.3%
Earnings Yield (TTM)	-72.8%	-72.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,927.9	0.0
EV/GP/RG	N/A	N/A
Ticker research	View KRRO research	View NKTX research

Valuation

P/S Ratio

NKTX

0.00x

KRRO

61.51x

EV/FCF

KRRO

-1.78x

NKTX

-1.45x

Growth & revenue

Revenue Growth TTM

KRRO

-62.1%

Forward Revenue Growth

NKTX

2561.2%

KRRO

240.0%

Profitability & performance

Gross Margin

KRRO

0.0%

NKTX

0.0%

ROE

NKTX

-3964.0%

KRRO

-11426.0%

FCF Yield %

KRRO

-46.6%

NKTX

-58.3%

52-Week Performance

NKTX

7.7%

KRRO

-77.8%

Detailed metrics comparison

KRRO

Korro Bio Inc

NKTX

Nkarta Inc

Market Cap

KRRO$147M

NKTX$161M

Enterprise Value

KRRO$122M

NKTX$136M

Price

KRRO$10.16

NKTX$2.25

P/E Ratio

KRRON/A

NKTXN/A

P/S Ratio

KRRO61.51x

NKTX0.00x

EV/Sales

KRRO51.05x

NKTX0.00x

EV/EBITDA

KRRO0.00x

NKTX0.00x

P/B Ratio

KRRO1.38x

NKTX0.74x

P/FCF Ratio

KRRON/A

NKTXN/A

EV/FCF

KRRO-1.78x

NKTX-1.45x

PEG Ratio

KRRON/A

NKTXN/A

Forward P/E (NTM)

KRRON/A

NKTXN/A

Forward P/S (NTM)

KRRO143.63x

NKTXN/A

Revenue (TTM)

KRRO$2M

NKTX$0

Revenue Growth (YoY)

KRRO-62.1%

NKTXN/A

Forward Rev Growth

KRRO240.0%

NKTX2561.2%

Gross Margin (TTM)

KRRO0.0%

NKTX0.0%

Operating Margin (TTM)

KRRO0.0%

NKTX0.0%

EBITDA Margin (TTM)

KRRO-3068.6%

NKTX0.0%

Net Margin (TTM)

KRRO-4477.1%

NKTX0.0%

FCF Margin (TTM)

KRRO-2865.9%

NKTXN/A

Net Income (TTM)

KRRO$-107M

NKTX$-117M

FCF (TTM)

KRRO$-68M

NKTX$-94M

EPS (TTM)

KRRO-$6.05

NKTX-$1.57

ROE (TTM)

KRRO-11426.0%

NKTX-3964.0%

ROA (TTM)

KRRO-6857.0%

NKTX-3045.0%

ROIC (TTM)

KRRO-11426.0%

NKTX-3964.0%

Cash

KRRO$25M

NKTX$25M

Debt

KRRO$0

NKTX$0

Net Cash/Debt

KRRO$25M

NKTX$25M

Current Ratio (TTM)

KRRO9.55x

NKTX7.98x

Quick Ratio (TTM)

KRRO9.11x

NKTX7.76x

Debt/Equity (TTM)

KRRO0.00x

NKTX0.00x

Debt/Assets (TTM)

KRRO0.0%

NKTX0.0%

Interest Coverage (TTM)

KRRON/A

NKTXN/A

Net Debt/EBITDA (TTM)

KRRO0.00x

NKTX0.00x

Beta

KRRO3.27

NKTX1.19

52W Performance

KRRO-77.8%

NKTX7.7%

YTD Performance

KRRO26.2%

NKTX20.3%

% from 52W High

KRRO-81.8%

NKTX-39.5%

% from 52W Low

KRRO95.2%

NKTX32.4%

Asset Turnover (TTM)

KRRO0.04x

NKTX0.00x

FCF Yield (TTM)

KRRO-46.6%

NKTX-58.3%

Earnings Yield (TTM)

KRRO-72.8%

NKTX-72.9%

Dividend Yield (TTM)

KRRON/A

NKTXN/A

Rule of 40

KRRO-2,927.9

NKTX0.0

EV/GP/RG

KRRON/A

NKTXN/A

Ticker research

View KRRO research View NKTX research

Metric	KRRO Korro Bio Inc	NKTX Nkarta Inc
Market & Valuation
Market Cap	$147M	$161M
Enterprise Value	$122M	$136M
Price	$10.16	$2.25
P/E Ratio	N/A	N/A
P/S Ratio	61.51x	0.00x
EV/Sales	51.05x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.38x	0.74x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.78x	-1.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	143.63x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-62.1%	N/A
Forward Rev Growth	240.0%	2561.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3068.6%	0.0%
Net Margin (TTM)	-4477.1%	0.0%
FCF Margin (TTM)	-2865.9%	N/A
Net Income (TTM)	$-107M	$-117M
FCF (TTM)	$-68M	$-94M
EPS (TTM)	-$6.05	-$1.57
ROE (TTM)	-11426.0%	-3964.0%
ROA (TTM)	-6857.0%	-3045.0%
ROIC (TTM)	-11426.0%	-3964.0%
Financial Health
Cash	$25M	$25M
Debt	$0	$0
Net Cash/Debt	$25M	$25M
Current Ratio (TTM)	9.55x	7.98x
Quick Ratio (TTM)	9.11x	7.76x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.27	1.19
52W Performance	-77.8%	7.7%
YTD Performance	26.2%	20.3%
% from 52W High	-81.8%	-39.5%
% from 52W Low	95.2%	32.4%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.00x
FCF Yield (TTM)	-46.6%	-58.3%
Earnings Yield (TTM)	-72.8%	-72.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,927.9	0.0
EV/GP/RG	N/A	N/A
Ticker research	View KRRO research	View NKTX research